Colorectal Cancer (CRC) Archives - Medical Conferences

No benefit of high-dose vitamin D3 supplementation in mCRC

Presented By

Dr Kimmie Ng, Dana-Farber Cancer Institute, MA, USA

Trial

Phase 3, SOLARIS

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 12:51

More highlights in Colorectal Cancer

Trial

POCHI, LEANOX

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 12:48

Post-operative MRD status more prognostic than TNM stage

Presented By

Dr Arvind Dasari, MD Anderson Cancer Center, TX, USA

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:48

CAPRI 2 GOIM trial navigates biomarker-driven therapy

Presented By

Dr Giulia Martini, University of Campania Luigi Vanvitelli, Italy

Trial

Phase 2, CAPRI 2 GOIM

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:44

Meta-analysis of triplet therapy in BRAFV600E-mutated mCRC

Presented By

Dr Davi Said G. Celso, Federal University of Viçosa, Brazil

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:41

CheckMate 8HW: Nivolumab/ipilimumab in MSI-H/dMMR mCRC

Presented By

Dr Sara Lonardi, Veneto Institute of Oncology, Italy

Trial

Phase 3, CheckMate 8HW

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:39

Sequence effect for third-line treatment of mCRC

Presented By

Prof. Michel Ducreux, Gustave Roussy, France

Trial

Phase 2, SOREGATT

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:36

REGINA meets stage 1 endpoint in rectal cancer and moves to stage 2 with reduced dose regorafenib

Presented By

Dr Francesco Sclafani, Institut Jules Bordet, Belgium

Trial

Phase 2, REGINA

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:34

High efficacy of pembrolizumab combined with standard therapy in patients with MSS/pMMR mCRC and high immune infiltrate

Presented By

Prof. David Tougeron, Poitiers University Hospital, France

Trial

Phase 2, POCHI

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:31

Prognostic value of ctDNA in stage III colon cancer

Presented By

Prof. Julien Taieb, Paris Descartes University, France

Trial

Phase 3, IDEA-France, IDEA-Greece

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:28

Neoadjuvant combined immunotherapy also effective in MSS/pMRR CRC

Presented By

Dr Mehraneh Jafari, Weill Cornell Medical Center, NY, USA

Trial

Phase 2, NEST-1

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:25

Neoadjuvant immunotherapy plus radiation effective in advanced MSI-H rectal cancer

Trial

Phase 2, ECOG-ACRIN EA2201

Type

Peer-reviewed article

21 August 2024 11:19

Peri- or post-operative chemotherapy benefits patients with resectable CRCLM

Presented By

Dr Giacomo Bregni, Brussels University Hospital, Belgium

Trial

Phase 3

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:12

TRANSMET meets OS endpoint

Presented By

Dr Maximiliano Gelli, Gustave Roussy, France

Trial

TRANSMET

Conference

ESMO GI 2024

Type

Peer-reviewed article

21 August 2024 11:05

Thermal ablation of small-size colorectal liver metastases is non-inferior to resection

Presented By

Prof. Martijn Meijerink, Amsterdam UMC, the Netherlands

Trial

Phase 3, COLLISION

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:48

Benefit of first-line nivolumab/ipilimumab in MSI-H/dMMR metastatic CRC

Presented By

Prof. Heinz-Josef Lenz, University of Southern California Norris Comprehensive Cancer Center, CA, USA

Trial

Phase 3, CheckMate 8HW

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:44

Neoadjuvant checkpoint blockade in MSI-H/dMMR CRC

Trial

Phase 1/2, NICHE-2, NEOPRISM-CRC

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:36

CodeBreaK 300: Promising survival trends in KRAS G12C-mutated mCRC

Presented By

Prof. Marwan Fakih, City of Hope Comprehensive Cancer Center, CA, USA

Trial

Phase 3, CodeBreaK 300

Conference

ASCO 2024

Type

Peer-reviewed article

18 July 2024 15:26

PREEMPT CRC: Blood-based screening test for colorectal cancer shows promise

Presented By

Dr Aasma Shaukat, New York University, USA

Trial

PREEMPT CRC

Conference

DDW 2024

Type

Peer-reviewed article

11 July 2024 12:33

Interview: The winding road to curing metastatic colorectal cancer

Expert

Dr Eduard Batlle, Institute for Research in Biomedicine Barcelona, Spain

23 February 2024 15:22

CheckMate 8HW: Excellent results for nivolumab plus ipilimumab in MSI-H/dMMR mCRC

Presented By

Prof. Thierry André, Sorbonne University, France

Trial

Phase 3, CheckMate 8HW

Conference

ASCO GI 2024

Type

News article

13 February 2024 12:44

Can ctDNA-directed therapy improve outcomes in low-risk colon cancer?

Presented By

Dr Van Morris, MD Anderson Cancer Center, TX, USA

Trial

Phase 2, NRG-GI005 (COBRA)

Conference

ASCO GI 2024

Type

News article

13 February 2024 12:40

Clinical biomarkers may guide therapy selection in RAS wildtype mCRC

Presented By

Dr Julian Holch, Ludwig-Maximilians-University of Munich, Germany

Trial

Phase 3, FIRE-3 (AIO KRK0306)

Conference

ASCO GI 2024

Type

News article

13 February 2024 12:31

Laparoscopic or open surgery in low rectal cancer?

Presented By

Prof. Pan Chi, Fujian Medical University, China

Trial

LASRE

Conference

ASCO GI 2024

Type

News article

13 February 2024 12:27

Investigational agent DKN-01 promising for advanced MSS CRC

Presented By

Dr Meredith Pelster, Sarah Cannon Research Institute, TN, USA

Trial

Phase 2, DeFianCe

Conference

ASCO GI 2024

Type

News article

13 February 2024 12:10

Neoadjuvant nivolumab/relatlimab demonstrates 100% pathological response in MMRd colon cancer

Presented By

Dr Yara Verschoor, Netherlands Cancer Institute, the Netherlands

Trial

Phase 2, NICHE-3

Conference

ESMO 2023

Type

Peer-reviewed article

18 December 2023 16:04

How to deal with at-risk patients above the CRC screening age limit?

Presented By

Dr Esther Toes-Zoutendijk, Erasmus University Medical Center, the Netherlands

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:05

European CRC screening needs to be revised

Presented By

Dr Julian Prosenz, Karl Landsteiner University of Health Sciences, Austria

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:02

7-year outcomes of PRODIGE 23 trial

Presented By

Prof. Thierry Conroy, Institut de Cancérologie de Lorraine, France

Trial

Phase 3, PRODIGE 23

Conference

ASCO 2023

Type

Peer-reviewed article

2 August 2023 10:04

Neoadjuvant chemotherapy may be viable option in locally advanced colon cancer

Presented By

Dr Lars Hendrik Jensen, University of Southern Denmark, Denmark

Trial

Phase 3, NeoCol

Conference

ASCO 2023

Type

Peer-reviewed article

2 August 2023 10:00

De-escalation of neoadjuvant treatment of locally advanced rectal cancer is non-inferior

Presented By

Dr Deborah Schrag, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, PROSPECT

Conference

ASCO 2023

Type

Peer-reviewed article

2 August 2023 09:58

Colorectal cancer: Aspirin and NSAIDs could reduce the risk of early-onset adenomas

Presented By

Dr Cassandra Fritz, Washington University School of Medicine, MO, USA

Conference

DDW 2023

Type

News article

13 June 2023 13:38

PIPAC technique shows promise for unresectable colorectal peritoneal metastases

Presented By

Dr Vincent van de Vlasakker, Catharina Hospital, the Netherlands

Trial

Phase 2, CRC-PIPAC-II

Conference

DDW 2023

Type

News article

13 June 2023 13:36

Combination botensilimab plus balstilimab demonstrates promising activity in heavily pre-treated MSS CRC

Presented By

Prof. Anthony El-Khoueiry, Norris Comprehensive Cancer Center, CA, USA

Trial

Phase 1, C-800

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:06

Mutation-based selection to identify patients suitable for panitumumab treatment

Presented By

Dr Kohei Shitara, National Cancer Center Hospital East, Japan

Trial

Phase 3, PARADIGM

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 09:01

Fucoidan associated with quality-of-life benefits in patients with rectal cancer receiving CCRT

Presented By

Prof. Jaw-Yuan Wang, Pingtung Hospital, Taiwan

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:58

SUNLIGHT trial meets primary endpoint in refractory metastatic CRC

Presented By

Prof. Josep Tabernero, Val d’Hebron University Hospital and Institute of Oncology, Spain

Trial

Phase 3, SUNLIGHT

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:45

Does cell-free DNA influence MRD testing in post-operative colon cancer?

Presented By

Dr Stacey Cohen, University of Washington, WA, USA

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:41

OPERA: surgery may be avoided with adequate therapy in rectal cancer

Presented By

Prof. Arthur Sun Myint, Clatterbridge Cancer Centre, UK

Trial

Phase 3, OPERA

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:39

Can we improve total neoadjuvant therapy for rectal cancer?

Presented By

Dr Thomas George, University of Florida, FL, USA

Trial

Phase 2, NRG-GI002

Conference

ASCO GI 2023

Type

Peer-reviewed article

17 March 2023 08:36

Computer-aided colonoscopies improved adenoma detection rates

Presented By

Dr Michiel Maas, Raboud UMC, the Netherlands

Conference

UEGW 2022

Type

Peer-reviewed article

2 December 2022 09:44

Benefit of colon cancer screening with colonoscopy lower than anticipated

Presented By

Prof. Michael Bretthauer, Oslo University, Norway

Trial

Phase 3, NordICC

Conference

UEGW 2022

Type

Peer-reviewed article

2 December 2022 09:41

Screening-detected colorectal cancers may have superior surgical outcomes

Presented By

Dr Jannie Dressler, Bispebjerg Hospital, Denmark

Conference

UEGW 2022

Type

Peer-reviewed article

2 December 2022 09:37

High pathological responses to neoadjuvant immune checkpoint inhibition in locally advanced dMMR colon cancer

Presented By

Dr Miriam Chalabi, Netherlands Cancer Institute, the Netherlands

Trial

NICHE-2

Conference

ESMO 2022

Type

Peer-reviewed article

16 November 2022 17:28

Fruquintinib: a potential new treatment for patients with refractory mCRC

Presented By

Prof. Nageshwara Arvind Dasari, MD Anderson Cancer Centre, TX, USA

Trial

Phase 3, FRESCO-2

Conference

ESMO 2022

Type

Peer-reviewed article

16 November 2022 17:21

Second-line avelumab is effective in patients with MSI-H/dMMR mCRC

Presented By

Prof. Julien Taieb, Hopital European George Pompidou, France

Trial

Phase 2, SAMCO-PRODIGE 54

Conference

ESMO 2022

Type

Peer-reviewed article

16 November 2022 17:13

UEGW 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

UEGW 2022

13 October 2022 22:43

Panitumumab beats bevacizumab in RAS wildtype left-sided metastatic colorectal cancer

Presented By

Dr Takayuki Yoshino, National Cancer Center Hospital East, Japan

Trial

Phase 3, PARADIGM

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 15:19

Spectacular results for dostarlimab in mismatch repair deficient rectal cancer

Presented By

Dr Andrea Cercek, Memorial Sloan Kettering Cancer Center, NY, USA

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 15:14

Triplet chemotherapy beats doublet chemotherapy in colorectal cancer liver metastases

Presented By

Prof. Cornelis Punt, University Medical Center Utrecht, the Netherlands

Trial

Phase 3, CAIRO5

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 15:11

ASCO 2022 Highlights Podcast

Presented By

Dr Robert van den Heuvel, Medicom

Conference

ASCO 2022

21 June 2022 09:38

NIPICOL: New data on optimal ICI treatment duration in MSI/dMMR mCRC

Presented By

Dr Romain Cohen, Sorbonne University, France

Trial

Phase 2, NIPICOL

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:30

Dostarlimab may offer an alternative for dMMR rectal cancer

Presented By

Dr Melissa Lumish, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 2

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:28

DESTINY-CRC01: Maintained efficacy of T-DXd in mCRC

Presented By

Dr Takayuki Yoshino, National Cancer Center Hospital East, Japan

Trial

Phase 2, DESTINY-CRC01

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:26

Key updates in colorectal cancer screening

Presented By

Dr Robin Mendelsohn, Memorial Sloan Kettering Cancer Center, NY, USA

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:25

Impact of COVID-19 on screening for colorectal cancer

Presented By

Dr John Carethers, University of Michigan, MI, USA

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:23

Nivolumab plus standard-of-care does not meet primary endpoint for mCRC

Presented By

Dr Heinz-Josef Lenz, USC Norris Comprehensive Cancer Center, CA, USA

Trial

Phase 3, CheckMate 9X8

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:21

No benefit of additional oxaliplatin in elderly patients with mCRC

Presented By

Dr Tetsuya Hamaguchi, National Cancer Center, Japan

Trial

Phase 3, JCOG1018, RESPECT

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:19

Prognostic impact of early oxaliplatin discontinuation in colon cancer unravelled

Presented By

Dr Claire Gallois, Université de Paris, France

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:17

Long-course chemoradiation versus short-course radiotherapy in rectal cancer

Presented By

Dr Emma Holliday, MD Anderson Cancer Center, University of Texas, TX, USA

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:15

Analysis of metastasectomy in CRC reveals benefits and disparities

Presented By

Dr Jude Khatib (University of Texas, TX, USA

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:12

EPOCH trial: Subgroup analyses and additional endpoints for TARE plus chemo

Presented By

Dr William Harris, Seattle Cancer Care Alliance, WA, USA

Trial

Phase 3, EPOCH

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 10:09

ASCO GI 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ASCO GI 2022

8 February 2022 12:37

Neoadjuvant chemotherapy potential alternative to neoadjuvant chemoradiotherapy in LARC

Presented By

Dr Pei-Rong Ding, Sun Yat-sen University Cancer Center, China

Trial

Phase 3, CONVERT

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:43

Immune chemo-sensitisation looks promising in microsatellite-stable mCRC

Presented By

Dr Filippo Pietrantonio, Istituto Nazionale dei Tumori di Milano, Italy & Dr Chiara Cremolini, Azienda Ospedaliero-Universitaria Pisana, Italy

Trial

Phase 2, MAYA & AtezoTRIBE

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:42

Adagrasib shows promising clinical activity in heavily pretreated KRAS-mutated CRC

Presented By

Dr Jared Weiss, University of North Carolina at Chapel Hill, NC, USA

Trial

Phase 1/2, KRYSTAL-1

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:42

Automated detection of microsatellite status on unstained samples in early colon cancer

Presented By

Dr Frederik Großerüschkamp, Ruhr-Universität Bochum, Germany

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:41

Pembrolizumab benefits survival in MSI-H/dMMR metastastic colorectal cancer

Presented By

Prof. Thierry André, Sorbonne University, France

Trial

Phase 3, KEYNOTE 177

Conference

ASCO 2021

Type

Peer-reviewed article

12 August 2021 23:32

Panitumumab added to 5-FU/LV effective as maintenance therapy in patients with mCRC

Presented By

Prof. Dominik Modest, Charité Universitätsmedizin Berlin, Germany

Trial

Phase 3, PANAMA

Conference

ASCO 2021

Type

Peer-reviewed article

12 August 2021 22:34

Trastuzumab-deruxtecan showed promising activity in patients with HER2-expressing mCRC

Presented By

Dr Takayuki Yoshino, National Cancer Center Hospital East, Japan

Trial

Phase 2, DESTINY-CRC01

Conference

ASCO 2021

Type

Peer-reviewed article

12 August 2021 21:10

ECCO 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ECCO 2021

10 August 2021 08:17

Increased risk of rectal cancer after colectomy in IBD

Presented By

Dr Elena Akimenko, Gentofte Hospital, Denmark

Conference

ECCO 2021

Type

News article

2 July 2021 20:58

Risk of colorectal cancer is detected by low-pass whole genome sequencing

Presented By

Dr Ibrahim Al Bakir, Queen Mary University of London, UK

Conference

ECCO 2021

Type

News article

2 July 2021 19:03

First-line pembrolizumab shows superior PFS in MSI-H/dMMR mCRC

Presented By

Dr Kai-Keen Shiu, University College London Hospitals NHS Foundation Trust, UK

Trial

Phase 3, KEYNOTE-177

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:52

Short-course radiotherapy with delayed surgery better for elderly rectal cancer patients

Presented By

Dr Eric Francois, Centre Antoine-Lacassagne, France

Trial

PRODIGE 42-GERICO 12 NACRE

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:50

Circulating tumour DNA predicts recurrence in colorectal cancer

Presented By

Tenna Henriksen, Aarhus University, Denmark

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:48

Neoadjuvant pembrolizumab in locally-advanced rectal cancer: primary results

Presented By

Dr Osama Rahma, Dana-Farber Cancer Institute, USA

Trial

Phase 2

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:46

Prognostic value of tumour deposits in stage 3 colon cancer patients

Presented By

Dr Romain Cohen, Mayo Clinic, USA

Trial

Phase 3, CALGB/SWOG 80702

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:43

Ipilimumab/nivolumab plus panitumumab in patients with microsatellite-stable mCRC

Presented By

Dr Michael Lee, University of Texas MD Anderson Cancer Center, USA

Trial

Phase 2

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:41

Preliminary surgery salvage data after watch & wait policy from OPERA trial

Trial

Phase 3, OPERA

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:40

Predicting resistance to first-line FOLFOX plus bevacizumab in mCRC using circulating markers

Presented By

Prof. Thomas Seufferlein, University of Ulm, Germany

Trial

Phase 1/2, PERMAD

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:37

Final OS analyses comparing trifluridine/tipiracil + bevacizumab versus capecitabine + bevacizumab in first-line unresectable mCRC patients noneligible for intensive therapy

Presented By

Prof. Eric Van Cutsem, KU Leuven, Belgium

Trial

Phase 2, TASCO1

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:35

Maintenance treatment with cetuximab versus observation in RAS wildtype mCRC

Presented By

Dr Valérie Boige, Institut Gustave Roussy, France

Trial

Phase 2, PRODIGE 28-time UNICANCER

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:33

Duloxetine ameliorates oxaliplatin-induced peripheral neuropathy

Presented By

Dr Jeffrey Chi, Northwell Health Cancer Institute, NY, USA

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:31

Rechallenge of RAS/BRAF wildtype CRC with avelumab plus cetuximab

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:13

Surveillance after curative treatment for CRC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:11

Adjuvant chemotherapy less effective in elderly CRC patients

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:10

CRC disseminates using collective migration

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 12:30

Post-colonoscopy colorectal cancers in IBD patients

Presented By

Ms Frederikke S. Troelsen, Aarhus University Hospital, Denmark

Conference

UEGW 2020

Type

News article

2 November 2020 11:19

Pembrolizumab as first-line in MSI-H mCRC

Expert

Prof. Thierry André, St Antoine Hospital, France

Trial

Phase 3, KEYNOTE-177

Conference

ASCO 2020

17 September 2020 14:55

Risk of rectal, anal cancer increased in perianal CD

Presented By

Dr M.D. Wewer, University of Copenhagen, Copenhagen, Denmark

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 15:48

Mixed data: AMG 510 in tumours with KRASG12C

Presented By

Prof. Ramaswamy Govindan, Washington University, St Louis, USA

Conference

ESMO 2019

Type

Peer-reviewed article

26 November 2019 23:30

Preoperative chemotherapy for colon cancer

Presented By

Prof. Dion Morton, University of Birmingham, UK

Trial

FOxTROT, phase 2/3

Conference

ESMO 2019

Type

Peer-reviewed article

26 November 2019 23:20

Liquid biopsy identifies relapse in patients with colorectal cancer after surgery

Presented By

Prof. Julien Taieb, Hopital European Georges Pompidou, France

Trial

Phase 3, IDEA-FRANCE

Conference

ESMO 2019

Type

Peer-reviewed article

26 November 2019 21:17

Advanced colorectal cancer and BRAF mutations: triplet combination improves survival

Presented By

Prof. Scott Kopetz, MD Anderson Cancer Center, Houston, USA

Trial

Phase 3, BEACON CRC

Conference

ESMO 2019

Type

Peer-reviewed article

26 November 2019 14:22

Ramosetron relieves low anterior resection syndrome

Presented By

Prof. Kyu Joo Park, Seoul National University Hospital, Korea

Conference

UEGW 2019

Type

Peer-reviewed article

23 October 2019 19:15

Global burden of digestive diseases reveals alarming trends

Trial

The Global Burden of Disease

Conference

UEGW 2019

Type

Peer-reviewed article

23 October 2019 17:46

IBD prevalence 3 times higher than estimated and expected to rise

Presented By

Dr Dominic King, University of Birmingham, UK

Conference

UEGW 2019

Type

Peer-reviewed article

23 October 2019 12:35

First-in-human study shows IL1RAP-targeting drug safe in solid tumours

Presented By

Dr Ahmad Awada, Institut Jules Bordet, Belgium

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 13:58

Long-term risk of advanced neoplasia after colonic low-grade dysplasia in IBD

Conference

ECCO 2018

Type

Peer-reviewed article

28 May 2018 23:13

Shallow whole-genome sequencing predicts future cancer risk of LGD in UC

Conference

ECCO 2018

Type

Peer-reviewed article

28 May 2018 21:30

Significantly increased risk of CRC and/or HGD after appendectomy in UC

Conference

ECCO 2018

Type

Peer-reviewed article

28 May 2018 18:43